The Globe and Mail reports in its Thursday, June 25, edition that ATB Cormark Capital Markets analyst Kyle McPhee has reaffirmed his "outperform" recommendation for Dexterra Group. The Globe's David Leeder writes in the Eye On Equities column that Mr. McPhee boosted his share target to $19.50, matching the consensus, from $14.25. Mr. McPhee says in a note: "Dexterra Group is firmly on our favorite picks list. The investment setup captures the ideal combo of durable growth, cheap valuation and meaningful forecast upside from multiple dynamics that we think carry good odds (organic demand capture and ongoing M&A). We are also fans of the disciplined management team that is strategically allocating capital and structurally enhancing the business." The Globe reported on Aug. 1, Oct. 7 and Nov. 7 that National Bank Financial analyst Zachary Evershed continued to rate Dexterra Group "outperform." The shares could then be had for $9.55, $9.95 and $10.26.